4

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: February 15, 2022
Period of Report: February 10, 2022
Accession Number: 0001096906-22-000339

View Document ↗ View on SEC.gov ↗